Merck IISP Stewardship Grant for Antibiotic Best Practices
The purpose of this study is to pilot the use of best practices alerts to enhance an antimicrobial stewardship program using the electronic medical record, EPIC.
|Study Design:||Time Perspective: Retrospective|
|Official Title:||Implementation of Antimicrobial Stewardship and Decision Support Into the EPIC Electronic Medical Record|
- Percentage of best practice alerts(BPA) that were completely accepted, partially accepted, or rejected within 72 hours of issuing the BPA [ Time Frame: One Year ] [ Designated as safety issue: No ]after issuing the BPA for deescalation, the responding healthcare provider will respond in one of the manners above
- The number and type of antiinfectives that were administered before and after(11days) the best practice alert is issued. [ Time Frame: One year ] [ Designated as safety issue: No ]The antiinfective use before and after the BPA will be analyzed in detail. The number of antibiotics, percentage decrease(or less likely increase) in antiinfectives in the 3 days before BPA , and 11 days after the BPA will be analyzed. A cost analysis will be performed. Patient outcomes will not be assessed.
|Study Start Date:||March 2011|
|Study Completion Date:||April 2012|
|Primary Completion Date:||April 2012 (Final data collection date for primary outcome measure)|
All prescribing MDs at UWHC
Observational for accept, reject, or accept with modification of Best Practice Alers
The purpose of this study is to pilot the use of best practices to enhance an antimicrobial stewardship program using the electronic medical record, EPIC. Screening information technology tools via SETNET/Safety SUrveyor(Premier) and the electronic anti-infective order form would allow for sufficient medical record review to create best practices alerts for the purpose of appropriate de-escalation of anti-invectives.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01573195
|United States, Wisconsin|
|University of Wisconsin Hospitals and Clinics|
|Madison, Wisconsin, United States, 53792|
|Principal Investigator:||Barry C Fox, MD||University of Wisconsin, Madison|